Pharma Focus Asia
Booming antibodies 2001
MasterControl - Learn How to Avoid Obstacles in Pharma Manufacturing
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

17

May 2022

PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing

PerkinElmer Inc a global leader committed to innovating for a healthier world today announced the availability of ultrarapid whole genome sequencing urWGS through PerkinElmer Genomics This addition to the Companys portfolio of whole genome sequencing WGS offerings provides physicians with comprehens...

17

May 2022

Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca

Proteros biostructures GmbH an expert in integrated structurebased drug discovery announces today an expansion of its collaboration with AstraZeneca focused on the discovery and development of novel epigenetic drugs The new multiyear agreement builds on an ongoing collaboration with AstraZeneca anno...

16

May 2022

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

Inmagene Biopharmaceuticals announces that today the US Food and Drug Administration FDA cleared its investigational new drug IND application for the drug candidate IMG a noncovalent reversible thirdgeneration Bruton Tyrosine Kinase BTK inhibitor to proceed to the Phase I clinical trial Inmagene is...

13

May 2022

Neurocrine Biosciences Receives Orphan Drug Designation for Valbenazine as a Treatment for Chorea Associated with Huntington Disease

Neurocrine Biosciences Inc announced that it has received Orphan Drug Designation from the US Food and Drug Administration FDA for valbenazine as a treatment for Huntington disease HD The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation In December Neurocri...

13

May 2022

Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014

Mindset Pharma Inc a drug discovery and development company focused on creating optimized and patentable nextgeneration psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs today announced that it is making headway in progressing its Family lead clinical ca...

12

May 2022

Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases

Nuvig Therapeutics Inc announced today the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function To support this mission the company has closed a million Series A financing led by No...

press releasesRead more...

16

May 2022

AbbVie and Cugene Announce Collaboration in Autoimmune Diseases

AbbVie and Cugene Inc a clinicalstage biotechnology company focused on developing nextgeneration precision immunology and oncology medicines to treat autoimmune disease and cancer today announced an exclusive worldwide license option agreement for CUG a potential bestinclass Tregselective IL mutein...

16

May 2022

Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages

Emergent BioSolutions Inc announced today that it has entered into a definitive agreement with Chimerix Inc to acquire Chimerixs exclusive worldwide rights to TEMBEXA brincidofovir the first antiviral approved by the US Food and Drug Administration FDA for all age groups for the treatment of smallpo...

16

May 2022

Athenex Announces Clinical Collaboration with Merck to Evaluate Oraxol plus KEYTRUDA® (pembrolizumab) in Patients with Non-Small Cell Lung Cancer (NSCLC)

Athenex Inc a global biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies for the treatment of cancer and related conditions today announced a clinical trial collaboration and supply agreement with Merck known as MSD outside the US and Canada The...

16

May 2022

ScPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

ScPharmaceuticals Inc a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies advance patient care and reduce healthcare costs today announced that the Companys New Drug Application NDA for FUROSCIX a proprieta...

16

May 2022

Travere Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Sparsentan for the Treatment of IgA Nephropathy

Travere Therapeutics Inc announced the US Food and Drug Administration FDA has accepted and granted Priority Review of its New Drug Application NDA under Subpart H for accelerated approval of sparsentan for the treatment of IgA nephropathy IgAN The FDA has indicated that it is not currently planning...

12

May 2022

Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers

Crown Bioscience and Medical Biological Laboratories MBL JSR Life Sciences companies today announced the formation of a joint venture to further expand the provision of Crown Biosciences preclinical services to Japanese customers The new entity named Crown Bioscience MBL is a longterm strategic pa...

EventsRead more...

17 - 18

May 2022

Clinical Trials Innovation Programme

Boston

18 - 22

May 2022

Cognitive Neuroscience

Helsinki Workers' House

23 - 24

May 2022

Psychedelic Therapeutics and Drug

Washington

24 - 26

May 2022

Liquid Biopsies

Bergamo

26 - 29

May 2022

Middle East Obstetrics & Gynecology Conference

Roda Al Bustan Dubai Airport

27 - 29

May 2022

International Symposium on Clinical Neuroscience

Orlando World Center Marriott

30 - 01

May 2022

Gene Therapy Analytical Development

Hanson Wade
Victoria Park Plaza Hotel

01 - 03

Jun 2022

PharmaLytica 2022

Bombay Exhibition Centre

Testing The World Celebrating 70 Years of Nalgene
Development and Validation of a Platform Assay Method Using Variable Pathlength Technology for Oligonucleotide Drug Products
Bora Pharmaceuticals - CMDO making success
Medical Fair Asia 2022
Medical Manufacturing Asia 2022
THERMOFISHER SEA APAC EDC
APAC CT Design
APAC Pharma Virtual
Upm Raflatac

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    European Lead Factory

    Head of European Screening Centre

    Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature

  • Articles

    Single Domain Antibody

    Monoclonal and polyclonal antibodies Abs are wellcorroborated tools adopted in basic biomedical research and innovative key components of numerous therapeutic platforms today on the market The vast majority of the Abs are obtained from easily accessible laboratory animals such as mice hamsters and rabbits and consist of two heavy and two light chains

  • Techno Trends

    Roche’s Balovaptan Gets FDA’s Breakthrough Therapy Designation

    Roche announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for its investigational oral medicine Balovaptan It is a vasopressin a Va receptor antagonist for individuals with Autism Spectrum Disorder ASD The Va receptor has a role in mediating and modulating key social behaviours associated with individuals with the...

  • White Papers

    Operational Strategy Globalization in Life Sciences Companies

    Global Supply Chain Trends Overview This report highlights the results from PRTMs sixth annual survey of global supply chain trends The survey is designed to provide critical insight into how industry leaders are globalizing their supply chain operations to achieve competitive advantage in todays challenging business environment

Advisory Board

Stella Stergiopoulos

Stella

 .
Sanjoy Ray

Sanjoy Ray

 .
Rustom Mody

Rustom

 .
Phil Kaminsky

Phil

 .
Neil J Campbell

Neil J
Laurence Flint

Laurence

 .
Kenneth I Kaitin

Kenneth I

 .
Georg C Terstappen

Georg C

 .
Frank A Jaeger

Frank A

 .
Douglas Meyer

Douglas

 .
Christopher-Paul Milne

Christopher-
Alan S Louie

Alan S Louie

 .

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...